Remgro PEG
The PEG Ratio (Price/Earnings-to-Growth) of Remgro (REM.JO) as of Jul 27, 2026 is 18.95.
Get this data via API
Financial Data API
PEG
18.95
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of Remgro is 2026 18.95 . PEG Ratio (Price/Earnings-to-Growth) of Remgro was 2025 0.00 . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API
Remgro Stock analysis
What does Remgro do? Remgro Ltd is a diversified company that offers a wide range of products and services in various business sectors. The company was founded in 1990 and is based in Stellenbosch, South Africa. The company emerged from the acquisition of Rembrandt Group Ltd, which was founded by South African billionaire and philanthropist Anton Rupert. Remgro has been a diversified company since its inception, operating in various business sectors. The company is divided into three main areas: finance, healthcare, and infrastructure. Some of the key holdings of Remgro in the finance sector include FirstRand Limited, RMB Holdings Limited, and Momentum Metropolitan Holdings Limited. In the healthcare sector, Remgro is active through its subsidiaries Mediclinic International plc and Erste Holdings Limited. Mediclinic operates clinics and hospitals in South Africa, the UK, and the UAE, offering a wide range of medical services. Erste Holdings is one of the largest pharmaceutical companies in South Africa, producing a wide range of medications and healthcare products. In the infrastructure sector, Remgro is involved through its stake in South African utility company PowerX, which is a leading provider of electricity and water in the country. Overall, Remgro is a diversified company operating in various sectors and offering a wide range of products and services. Remgro is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Remgro stock
PEG Ratio (Price/Earnings-to-Growth) of Remgro is 18.95 in 2026.
Access this data via the Eulerpool API
Valuation — Remgro
All Key Metrics — Remgro
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth